Abstract

Stent length as a potential indicator to select patients who may benefit from long-term dual antiplatelet therapy

Author(s): G Schurtz, A Manchuelle & G Lemesle

“There is to date sufficient data to show us that a 1-year DAPT is not necessarily the best regimen for all CAD patients and that a tailored approach might be warranted.”